Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma.
暂无分享,去创建一个
D. Huntsman | S. McKinney | M. Köbel | Erika Mehl | S. Kalloger | K. Swenerton | P. Leung | L. Prentice | B. Gilks | Samuel Aparicio | C. Klausen | C. Kenney | J. Santos